Changes in the metabolic profile of human male postmortem frontal cortex and cerebrospinal fluid samples associated with heavy alcohol use.
alcohol
alcoholism
brain
metabolomics
microbiota
Journal
Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
08
03
2021
received:
08
06
2020
accepted:
10
03
2021
pubmed:
22
3
2021
medline:
3
2
2022
entrez:
21
3
2021
Statut:
ppublish
Résumé
Heavy alcohol use is one of the top causes of disease and death in the world. The brain is a key organ affected by heavy alcohol use. Here, our aim was to measure changes caused by heavy alcohol use in the human brain metabolic profile. We analyzed human postmortem frontal cortex and cerebrospinal fluid (CSF) samples from males with a history of heavy alcohol use (n = 74) and controls (n = 74) of the Tampere Sudden Death Series cohort. We used a nontargeted liquid chromatography mass spectrometry-based metabolomics method. We observed differences between the study groups in the metabolite levels of both frontal cortex and CSF samples, for example, in amino acids and derivatives, and acylcarnitines. There were more significant alterations in the metabolites of frontal cortex than in CSF. In the frontal cortex, significant alterations were seen in the levels of neurotransmitters (e.g., decreased levels of GABA and acetylcholine), acylcarnitines (e.g., increased levels of acylcarnitine 4:0), and in some metabolites associated with alcohol metabolizing enzymes (e.g., increased levels of 2-piperidone). Some of these changes were also significant in the CSF samples (e.g., elevated 2-piperidone levels). Overall, these results show the metabolites associated with neurotransmitters, energy metabolism and alcohol metabolism, were altered in human postmortem frontal cortex and CSF samples of persons with a history of heavy alcohol use.
Substances chimiques
Neurotransmitter Agents
0
acylcarnitine
0
Carnitine
S7UI8SM58A
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13035Informations de copyright
© 2021 The Authors. Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2018;392(10152):1015-1035.
de la Monte SM, Kril JJ. Human alcohol-related neuropathology. Acta Neuropathol (Berl). 2014;127:71-90.
Abrahao KP, Salinas AG, Lovinger DM. Alcohol and the brain: neuronal molecular targets, synapses, and circuits. Neuron. 2017;96(6):1223-1238.
Voutilainen T, Kärkkäinen O. Changes in the human metabolome associated with alcohol use: a review. Alcohol Alcohol. 2019;54(3):225-234.
Jaremek M, Yu Z, Mangino M, et al. Alcohol-induced metabolomic differences in humans. Transl Psychiatry. 2013;3(7):e276-e276.
Würtz P, Cook S, Wang Q, et al. Metabolic profiling of alcohol consumption in 9778 young adults. Int J Epidemiol. 2016;45(5):1493-1506.
Lehikoinen AI, Kärkkäinen OK, Lehtonen MAS, Auriola SOK, Hanhineva KJ, Heinonen ST. Alcohol and substance use are associated with altered metabolome in the first trimester serum samples of pregnant mothers. Eur J Obstet Gynecol Reprod Biol. 2018;223:79-84.
Heikkinen N, Kärkkäinen O, Laukkanen E, et al. Changes in the serum metabolite profile correlate with decreased brain gray matter volume in moderate-to-heavy drinking young adults. Alcohol. 2019;75:89-97.
Shen Q, Heikkinen N, Kärkkäinen O, et al. Effects of long-term adolescent alcohol consumption on white matter integrity and their correlations with metabolic alterations. Psychiatry Res Neuroimaging. 2019;294:111003.
Meinhardt MW, Sévin DC, Klee ML, Dieter S, Sauer U, Sommer WH. The neurometabolic fingerprint of excessive alcohol drinking. Neuropsychopharmacology. 2015;40(5):1259-1268.
Meyerhoff DJ. Brain proton magnetic resonance spectroscopy of alcohol use disorders. In: Handbook of Clinical Neurology. Vol.125. Elsevier; 2014:313-337.
Kashem MA, Ahmed S, Sultana N, et al. Metabolomics of neurotransmitters and related metabolites in post-mortem tissue from the dorsal and ventral striatum of alcoholic human brain. Neurochem Res. 2016;41(1-2):385-397.
Kärkkäinen OK, Lehtonen M, Laukkanen V, et al. Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics. Alcohol. 2013;47(5):399-403.
Kärkkäinen O, Häkkinen MR, Auriola S, Kautiainen H, Tiihonen J, Storvik M. Increased steroid hormone dehydroepiandrosterone and pregnenolone levels in post-mortem brain samples of alcoholics. Alcohol. 2016;52:63-70.
Klåvus A, Kokla M, Noerman S, et al. “notame”: workflow for non-targeted LC-MS metabolic profiling. Metabolites. 2020;10(4):135.
Tsugawa H, Cajka T, Kind T, et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12(6):523-526.
Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis: chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics. 2007;3(3):211-221.
Behar KL, Rothman DL, Petersen KF, et al. Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry. 1999;156(6):952-954.
Mason GF, Petrakis IL, de Graaf RA, et al. Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry. 2006;59(1):85-93.
Mon A, Durazzo TC, Meyerhoff DJ. Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. Drug Alcohol Depend. 2012;125(1-2):27-36.
Laukkanen V, Storvik M, Häkkinen M, et al. Decreased GABAA benzodiazepine binding site densities in postmortem brains of Cloninger type 1 and 2 alcoholics. Alcohol. 2013;47(2):103-108.
Augier E, Barbier E, Dulman RS, et al. A molecular mechanism for choosing alcohol over an alternative reward. Science. 2018;360(6395):1321-1326.
Callery PS, Geelhaar LA. Biosynthesis of 5-aminopentanoic acid and 2-piperidone from cadaverine and 1-piperideine in mouse. J Neurochem. 1984;43(6):1631-1634.
Cheng J, Chen C, Kristopher KW, et al. Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping. Toxicol Sci off J Soc Toxicol. 2013;135(1):37-47.
Heit C, Dong H, Chen Y, Thompson DC, Deitrich RA, Vasiliou VK. The role of CYP2E1 in alcohol metabolism and sensitivity in the central nervous system. Subcell Biochem. 2013;67:235-247.
Wu J, Gao M, Taylor DH. Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence. Acta Pharmacol Sin. 2014;35(3):311-315.
Masamune A, Sakai Y, Yoshida M, Satoh A, Satoh K, Shimosegawa T. Lysophosphatidylcholine activates transcription factor NF-κB and AP-1 in AR42J cells. Dig Dis Sci. 2001;46(9):1871-1881.
Inose Y, Kato Y, Kitagawa K, Uchiyama S, Shibata N. Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes: LPC activates microglia in penumbra. Neuropathology. 2015;35(3):209-223.
Loppi S, Kolosowska N, Kärkkäinen O, et al. HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage. Brain Behav Immun. 2018;73:670-681.
Klavins K, Koal T, Dallmann G, Marksteiner J, Kemmler G, Humpel C. The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment. Alzheimers Dement Diagn Assess Dis Monit. 2015;1:295-302.
Jagannathan NR, Desai NG, Raghunathan P. Brain metabolite changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging. 1996;14(5):553-557.
Seitz D, Widmann U, Seeger U, et al. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics. Alcohol Clin Exp Res. 1999;23(1):158-163.
Bendszus M, Weijers H-G, Wiesbeck G, et al. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: correlation with clinical and neuropsychological data. Am J Neuroradiol. 2001;22(10):1926-1932.
Parks MH, Dawant BM, Riddle WR, et al. Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res. 2002;26(9):1368-1380.
Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ. Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcohol Clin Exp Res. 2004;28(12):1849-1860.
Ende G, Welzel H, Walter S, et al. Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58(12):974-980.
Wang JJ, Durazzo TC, Gazdzinski S, Yeh P-H, Mon A, Meyerhoff DJ. MRSI and DTI: a multimodal approach for improved detection of white matter abnormalities in alcohol and nicotine dependence. NMR Biomed. 2009;22(5):516-522.
Yudkoff M, Daikhin Y, Nissim I, et al. Response of brain amino acid metabolism to ketosis. Neurochem Int. 2005;47(1-2):119-128.
Baslow MH. N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 2003;28(6):941-953.
Baslow M, Guilfoyle D. Using proton magnetic resonance imaging and spectroscopy to understand brain “activation”. Brain Lang. 2007;102(2):153-164.
Rigotti DJ, Inglese M, Gonen O. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. Am J Neuroradiol. 2007;28(10):1843-1849.
Nordengen K, Heuser C, Rinholm JE, Matalon R, Gundersen V. Localisation of N-acetylaspartate in oligodendrocytes/myelin. Brain Struct Funct. 2015;220(2):899-917.
Lacruz ME, Kluttig A, Tiller D, et al. Cardiovascular risk factors associated with blood metabolite concentrations and their alterations during a 4-year period in a population-based cohort. Circ Cardiovasc Genet. 2016;9(6):487-494.
van Roekel E, Trijsburg L, Assi N, et al. Circulating metabolites associated with alcohol intake in the European prospective investigation into cancer and nutrition cohort. Nutrients. 2018;10(5):654.
Sealey WM, Teague AM, Stratton SL, Mock DM. Smoking accelerates biotin catabolism in women. Am J Clin Nutr. 2004;80(4):932-935.